Alzheimer's Disease Trial, Recruiting (NCT07659964)

Alzheimer's Disease Trial, Recruiting NCT07659964 Sponsor: Boston University Charles River Campus Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07659964 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You live in the community (not in a care facility)
You are able to walk short distances (around 10–15 minutes at a time) on your own, without help from another person or a walking aid like a cane
You are able to communicate with the research team
You are between 50 and 90 years old (inclusive)
If you do not have Alzheimer's disease: you have no diagnosis of Alzheimer's disease
If you do have Alzheimer's disease: you score within a certain range on memory and thinking tests called the MoCA (score 20–30) and MMSE (score 25–30), and show some memory or thinking difficulties on another test called the CERAD (confirm with trial site for exact score details)

Who may not be able to join:

You have a significant hearing impairment
You have a current bone, joint, nerve, or other health condition that affects your ability to walk

A note on testing:

After agreeing to take part, you will be asked to complete some in-person memory and thinking tests; if your results do not meet the study's requirements, you will be told you are not eligible and your study visit will be cancelled

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07659964

Sponsor: Boston University Charles River Campus

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

More information: https://clinicaltrials.gov/study/NCT07659964

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You live in the community (not in a care facility)
You are able to walk short distances (around 10–15 minutes at a time) on your own, without help from another person or a walking aid like a cane
You are able to communicate with the research team
You are between 50 and 90 years old (inclusive)
If you do not have Alzheimer's disease: you have no diagnosis of Alzheimer's disease
If you do have Alzheimer's disease: you score within a certain range on memory and thinking tests called the MoCA (score 20–30) and MMSE (score 25–30), and show some memory or thinking difficulties on another test called the CERAD (confirm with trial site for exact score details)

Who may not be able to join:

You have a significant hearing impairment
You have a current bone, joint, nerve, or other health condition that affects your ability to walk

A note on testing:

After agreeing to take part, you will be asked to complete some in-person memory and thinking tests; if your results do not meet the study's requirements, you will be told you are not eligible and your study visit will be cancelled

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Boston University Charles River Campus

Registry

ClinicalTrials.gov

Start date

1 June 2026

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Functional brain network connectivity; Stride time variability; Gait speed

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov